These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31484544)

  • 1. Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.
    Gotschy A; von Deuster C; van Gorkum RJH; Gastl M; Vintschger E; Schwotzer R; Flammer AJ; Manka R; Stoeck CT; Kozerke S
    J Cardiovasc Magn Reson; 2019 Sep; 21(1):56. PubMed ID: 31484544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance imaging of functional and microstructural changes of the heart in a longitudinal pig model of acute to chronic myocardial infarction.
    Stoeck CT; von Deuster C; Fuetterer M; Polacin M; Waschkies CF; van Gorkum RJH; Kron M; Fleischmann T; Cesarovic N; Weisskopf M; Kozerke S
    J Cardiovasc Magn Reson; 2021 Sep; 23(1):103. PubMed ID: 34538266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
    Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between myocardial microstructure and strain in chronic infarction using cardiovascular magnetic resonance diffusion tensor imaging and feature tracking.
    Sharrack N; Das A; Kelly C; Teh I; Stoeck CT; Kozerke S; Swoboda PP; Greenwood JP; Plein S; Schneider JE; Dall'Armellina E
    J Cardiovasc Magn Reson; 2022 Nov; 24(1):66. PubMed ID: 36419059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
    Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in-vivo comparison of stimulated-echo and motion compensated spin-echo sequences for 3 T diffusion tensor cardiovascular magnetic resonance at multiple cardiac phases.
    Scott AD; Nielles-Vallespin S; Ferreira PF; Khalique Z; Gatehouse PD; Kilner P; Pennell DJ; Firmin DN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):1. PubMed ID: 29298692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
    Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT
    Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
    Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis.
    Kim JY; Hong YJ; Han K; Lee HJ; Hur J; Kim YJ; Choi BW
    Korean J Radiol; 2021 Jun; 22(6):880-889. PubMed ID: 33686816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.
    Lehmonen L; Kaasalainen T; Atula S; Mustonen T; Holmström M
    Int J Cardiovasc Imaging; 2019 Feb; 35(2):351-358. PubMed ID: 30848402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial extracellular volume quantification in cardiac amyloidosis: a comparative study between cardiac computed tomography and magnetic resonance imaging.
    Hayashi H; Oda S; Kidoh M; Yamaguchi S; Yoshimura F; Takashio S; Usuku H; Nagayama Y; Nakaura T; Ueda M; Tsujita K; Hirai T
    Eur Radiol; 2024 Feb; 34(2):1016-1025. PubMed ID: 37597032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
    Dolan RS; Stillman AE; Davarpanah AH
    Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.
    Avitzur N; Satriano A; Afzal M; Narous M; Mikami Y; Hansen R; Dobko G; Flewitt J; Lydell CP; Howarth AG; Chow K; Fine NM; White JA
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1937-1946. PubMed ID: 30014362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
    Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.